Clinical Trial Detail

NCT ID	NCT02715531
Title	A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Hoffmann-La Roche
Indications	gastroesophageal junction adenocarcinoma pancreatic cancer esophageal cancer hepatocellular carcinoma gastric adenocarcinoma
Therapies	Capecitabine Atezolizumab + Cisplatin + Fluorouracil Atezolizumab + Gemcitabine + Nab-paclitaxel Atezolizumab + Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin Atezolizumab + Bevacizumab Atezolizumab + Fluorouracil + Leucovorin + Oxaliplatin
Age Groups:	senior adult